The cancer biologics market will register a CAGR of over 11% by 2023

Tuesday, May 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, May 6, 2019 /PRNewswire/ -- About this marketThe rising global incidences of cancer are likely to impact the market's growth during the forecast period. Increasing prevalence of environmental factors including tobacco smoking and pollution and changing dietary patterns are expected to contribute directly to the increased global incidences of cancer. Such

rising incidences of this condition will eventually contribute to the cancer biologics market growth during the forecast period. Analysts have predicted that the cancer biologics market will register a CAGR of over 11% by 2023.Download the full report: https://www.reportbuyer.com/product/5773797/?utm_source=PRN Market OverviewThe rising global incidence of cancerThe major etiological factors leading to cancer include genetic mutations, environmental factors such as tobacco smoking and pollution, and changing dietary patterns. The rising prevalence of these factors has directly contributed to the increased global incidence of cancer.Patient expiry of major cancer biologicsThe emergence of biosimilars due to patent expiration of biologics hinder the market growth, despite the increased incidence of cancer during the forecast period.For the detailed list of factors that will drive and challenge the growth of the cancer biologics market during 2019-2023, view our report.Competitive LandscapeThe market appears to be highly concentrated with the presence of a few market players. Manufacturers in the global cancer biologics market are entering into strategic collaborations to develop or commercialize biologics indicated for the treatment of various types of cancer. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Download the full report: https://www.reportbuyer.com/product/5773797/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-cancer-biologics-market-will-register-a-cagr-of-over-11-by-2023-300844340.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store